3 December 2018
Surgical Innovations Group plc ("Surgical Innovations" or "the "Company")
Appointment of Nominated Adviser and Broker
Surgical Innovations (AIM: SUN), the designer and manufacturer of innovative technology for minimally invasive surgery, announces the appointment of Nplus1 Singer Advisory LLP ("N+1 Singer") as Nominated Adviser and sole Broker to the Company with immediate effect.
For further information contact:
Surgical Innovations Group Plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: +44 (0)113 230 7597 |
Melanie Ross, COO and CFO | |
Walbrook PR (Financial PR & Investor Relations) | Tel: +44 (0)20 7933 8780 orsi@walbrookpr.com |
Paul McManus | Mob: +44 (0)7980 541 893 |
Lianne Cawthorne | Mob: +44 (0)7584 391 303 |
N+1 Singer - Nominated Adviser and Broker | +44 (0)20 7496 3000 |
Richard Lindley | |
Rachel Hayes |
Attachments
- Original document
- Permalink
Disclaimer
Surgical Innovations Group plc published this content on 03 December 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 03 December 2018 09:11:05 UTC